Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001140361-21-014779
Filing Date
2021-04-28
Accepted
2021-04-28 16:36:37
Documents
14
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A brhc10023584_10ka.htm   iXBRL 10-K/A 1025672
2 EXHIBIT 31.1 brhc10023584_ex31-1.htm EX-31.1 6760
3 EXHIBIT 31.2 brhc10023584_ex31-2.htm EX-31.2 6599
  Complete submission text file 0001140361-21-014779.txt   1320001

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tlry-20201231.xsd EX-101.SCH 3917
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlry-20201231_lab.xml EX-101.LAB 26963
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlry-20201231_pre.xml EX-101.PRE 19071
7 EXTRACTED XBRL INSTANCE DOCUMENT brhc10023584_10ka_htm.xml XML 8514
Mailing Address 1100 MAUGHAN ROAD NANAIMO A1 V9X 1J2
Business Address 1100 MAUGHAN ROAD NANAIMO A1 V9X 1J2 2064329325
Tilray, Inc. (Filer) CIK: 0001731348 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38594 | Film No.: 21864818
SIC: 2833 Medicinal Chemicals & Botanical Products